AU5909900A - Predicting immunotherapy effectiveness through delayed type hypersensitivity - Google Patents

Predicting immunotherapy effectiveness through delayed type hypersensitivity

Info

Publication number
AU5909900A
AU5909900A AU59099/00A AU5909900A AU5909900A AU 5909900 A AU5909900 A AU 5909900A AU 59099/00 A AU59099/00 A AU 59099/00A AU 5909900 A AU5909900 A AU 5909900A AU 5909900 A AU5909900 A AU 5909900A
Authority
AU
Australia
Prior art keywords
type hypersensitivity
delayed type
effectiveness
predicting immunotherapy
predicting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU59099/00A
Inventor
Suzin E. Mayerson
Floyd E. Taub
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LIFE TIME PHARMACEUTICALS Inc
Original Assignee
LIFE TIME PHARMACEUTICALS Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LIFE TIME PHARMACEUTICALS Inc filed Critical LIFE TIME PHARMACEUTICALS Inc
Publication of AU5909900A publication Critical patent/AU5909900A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0006—Skin tests, e.g. intradermal testing, test strips, delayed hypersensitivity

Landscapes

  • Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU59099/00A 1999-07-02 2000-06-30 Predicting immunotherapy effectiveness through delayed type hypersensitivity Abandoned AU5909900A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14205899P 1999-07-02 1999-07-02
US60142058 1999-07-02
PCT/US2000/018261 WO2001002013A1 (en) 1999-07-02 2000-06-30 Predicting immunotherapy effectiveness through delayed type hypersensitivity

Publications (1)

Publication Number Publication Date
AU5909900A true AU5909900A (en) 2001-01-22

Family

ID=22498405

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59099/00A Abandoned AU5909900A (en) 1999-07-02 2000-06-30 Predicting immunotherapy effectiveness through delayed type hypersensitivity

Country Status (2)

Country Link
AU (1) AU5909900A (en)
WO (1) WO2001002013A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017355512A1 (en) 2016-11-04 2019-05-23 Aximmune, Inc. Beta-alethine, immune modulators, and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5614610A (en) * 1984-12-21 1997-03-25 Oncogen Tumor immunotherapy using anti-idiotypic antibodies
US5776459A (en) * 1989-07-19 1998-07-07 Connetics Corporation TCR V beta 5 peptides
US5470730A (en) * 1990-09-28 1995-11-28 Immunex Method for producing TH -independent cytotoxic T lymphocytes

Also Published As

Publication number Publication date
WO2001002013A1 (en) 2001-01-11

Similar Documents

Publication Publication Date Title
AU2940800A (en) Refrigerator
AU2002357047A1 (en) Payment system
AU2003240991A1 (en) Payment system
AU2932000A (en) Lacing systems
AU2329199A (en) Absorbable microparticles
AU1491301A (en) Compressor assembly
AUPQ459599A0 (en) Improved mullion assembly
AU2003242600A1 (en) Solid mycoctoxin carriers
GB9927328D0 (en) Immunotherapy
AU6474400A (en) Compressor
AUPP999799A0 (en) New compound
AU5031000A (en) Caulking gun
AU6687900A (en) Phenoxy fluoropyrimidines
AU2003212776A1 (en) Microparticles
AU8019600A (en) Advanced backpack system
AU2003301316A1 (en) Improved immunotherapy
GB0010911D0 (en) Delayed egress system
AU5532600A (en) Control-cable fastening element
AU2003261240A1 (en) Fastening system
AU3984700A (en) Compound screening methods
AU5909900A (en) Predicting immunotherapy effectiveness through delayed type hypersensitivity
AU6853400A (en) Freezers
AU2003230674A1 (en) Enclosing system
AU5787901A (en) Compound
AU1275001A (en) Solid particles

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase